Literature DB >> 28499832

Versatile and precise gene-targeting strategies for functional studies in mammalian cell lines.

M Wassef1, A Luscan2, A Battistella3, S Le Corre3, H Li4, M R Wallace5, M Vidaud2, R Margueron3.   

Abstract

The advent of programmable nucleases such as ZFNs, TALENs and CRISPR/Cas9 has brought the power of genetic manipulation to widely used model systems. In mammalian cells, nuclease-mediated DNA double strand break is mainly repaired through the error-prone non-homologous end-joining (NHEJ) repair pathway, eventually leading to accumulation of small deletions or insertions (indels) that can inactivate gene function. However, due to the variable size of the indels and the polyploid status of many cell lines (e.g., cancer-derived cells), obtaining a knockout usually requires lengthy screening and characterization procedures. Given the more precise type of modifications that can be introduced upon homology-directed repair (HDR), we have developed HDR-based gene-targeting strategies that greatly facilitate the process of knockout generation in cell lines. To generate reversible knockouts (R-KO), a selectable promoter-less STOP cassette is inserted in an intron, interrupting transcription. Loss-of-function can be validated by RT-qPCR and is removable, enabling subsequent restoration of gene function. A variant of the R-KO procedure can be used to introduce point mutations. To generate constitutive knockouts (C-KO), an exon is targeted, which makes use of HDR-based gene disruption together with NHEJ-induced indels on non-HDR targeted allele(s). Hence the C-KO procedure greatly facilitates simultaneous inactivation of multiple alleles. Overall these genome-editing tools offer superior precision and efficiency for functional genetic approaches. We provide detailed protocols guiding in the design of targeting vectors and in the analysis and validation of gene targeting experiments.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CRISPR/CAS9; Constitutive knockout; Genome editing; Point mutation; Reversible knockout; Targeting vector

Mesh:

Substances:

Year:  2017        PMID: 28499832     DOI: 10.1016/j.ymeth.2017.05.003

Source DB:  PubMed          Journal:  Methods        ISSN: 1046-2023            Impact factor:   3.608


  10 in total

1.  A cis-acting mechanism mediates transcriptional memory at Polycomb target genes in mammals.

Authors:  Daniel Holoch; Michel Wassef; Cecilia Lövkvist; Dina Zielinski; Setareh Aflaki; Bérangère Lombard; Tiphaine Héry; Damarys Loew; Martin Howard; Raphaël Margueron
Journal:  Nat Genet       Date:  2021-11-15       Impact factor: 38.330

2.  Establishment of a conditional Nomo1 mouse model by CRISPR/Cas9 technology.

Authors:  Ignacio García-Tuñón; Elena Vuelta; Laura Lozano; María Herrero; Lucía Méndez; Javier Palomero-Hernandez; María Pérez-Caro; Jessica Pérez-García; Rogelio González-Sarmiento; Manuel Sánchez-Martín
Journal:  Mol Biol Rep       Date:  2019-12-12       Impact factor: 2.316

3.  Nesprin-2 accumulates at the front of the nucleus during confined cell migration.

Authors:  Patricia M Davidson; Aude Battistella; Théophile Déjardin; Timo Betz; Julie Plastino; Nicolas Borghi; Bruno Cadot; Cécile Sykes
Journal:  EMBO Rep       Date:  2020-05-17       Impact factor: 8.807

4.  Splice donor site sgRNAs enhance CRISPR/Cas9-mediated knockout efficiency.

Authors:  Ignacio García-Tuñón; Verónica Alonso-Pérez; Elena Vuelta; Sandra Pérez-Ramos; María Herrero; Lucía Méndez; Jesús María Hernández-Sánchez; Marta Martín-Izquierdo; Raquel Saldaña; Julián Sevilla; Fermín Sánchez-Guijo; Jesús María Hernández-Rivas; Manuel Sánchez-Martín
Journal:  PLoS One       Date:  2019-05-09       Impact factor: 3.240

Review 5.  Genome-Editing Technologies: Concept, Pros, and Cons of Various Genome-Editing Techniques and Bioethical Concerns for Clinical Application.

Authors:  Sikandar Hayat Khan
Journal:  Mol Ther Nucleic Acids       Date:  2019-04-03

6.  ESI mutagenesis: a one-step method for introducing mutations into bacterial artificial chromosomes.

Authors:  Arnaud Rondelet; Andrei Pozniakovsky; Devika Namboodiri; Richard Cardoso da Silva; Divya Singh; Marit Leuschner; Ina Poser; Andrea Ssykor; Julian Berlitz; Nadine Schmidt; Lea Röhder; Gerben Vader; Anthony A Hyman; Alexander W Bird
Journal:  Life Sci Alliance       Date:  2020-12-08

7.  Flow Assisted Mutation Enrichment (FAME): A highly efficacious and efficient method to enrich Double Knockouts (DKO) after gene editing.

Authors:  Michael Hansen; Xiaopin Cai; Sara Bowen; David A Largaespada; Ming V Li
Journal:  PLoS One       Date:  2021-03-04       Impact factor: 3.240

Review 8.  Future Approaches for Treating Chronic Myeloid Leukemia: CRISPR Therapy.

Authors:  Elena Vuelta; Ignacio García-Tuñón; Patricia Hernández-Carabias; Lucía Méndez; Manuel Sánchez-Martín
Journal:  Biology (Basel)       Date:  2021-02-04

9.  Application of CRISPR/Cas9-based mutant enrichment technique to improve the clinical sensitivity of plasma EGFR testing in patients with non-small cell lung cancer.

Authors:  Boyeon Kim; Yoonjung Kim; Saeam Shin; Seung-Tae Lee; Jae Yong Cho; Kyung-A Lee
Journal:  Cancer Cell Int       Date:  2022-02-15       Impact factor: 5.722

10.  BAP1 complex promotes transcription by opposing PRC1-mediated H2A ubiquitylation.

Authors:  Antoine Campagne; Ming-Kang Lee; Dina Zielinski; Audrey Michaud; Stéphanie Le Corre; Florent Dingli; Hong Chen; Lara Z Shahidian; Ivaylo Vassilev; Nicolas Servant; Damarys Loew; Eric Pasmant; Sophie Postel-Vinay; Michel Wassef; Raphaël Margueron
Journal:  Nat Commun       Date:  2019-01-21       Impact factor: 14.919

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.